Smarter Studies | Global Impact | Better Health

We are at the forefront of resolving internationally important questions.

The UCL Innovative Clinical Trials Unit (formerly the MRC Clinical Trials Unit at UCL) is at the forefront of resolving internationally important questions in infectious diseases, cancer and neurodegenerative diseases, and delivering swifter and more effective translation of scientific research into patient benefits. It does this by carrying out challenging and innovative studies, and developing and implementing methodological advances in study design, conduct and analysis.

We design and conduct clinical trials.

We design and conduct innovative and challenging clinical trials. We bring together the results of a number of trials which look at the same illness or condition (this is called a systematic review or meta-analysis). We also undertake observational studies to evaluate the impact of new interventions in routine care.

We are a registered Clinical Trials Unit at the UKCRC Registered CTUs Network.

Our research helps to improve healthcare around the world.

Our research helps to improve healthcare in the UK and around the world.

Our Vision

Focus on internationally important questions

Focus on internationally important questions, through challenging and innovative studies, concentrating on infectious diseases, cancer and neurodegenerative diseases.

Put methodology firmly at the heart of our work

We carry out methodological research to help us improve how studies are designed, conducted and analysed. This innovation is inspired by challenges faced by our studies, and helps ensure scientific progress is translated into clinical benefit more rapidly and effectively.